Forest Hill Capital’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-150,250
Closed -$601K 25
2025
Q4
$601K Hold
150,250
0.31% 32
2025
Q3
$1.27M Hold
150,250
0.75% 26
2025
Q2
$1.69M Sell
150,250
-19,500
-11% -$179K 1.2% 22
2025
Q1
$1.61M Buy
169,750
+25,000
+17% +$253K 1.2% 24
2024
Q4
$1.63M Buy
144,750
+100,000
+223% +$1.76M 1.26% 25
2024
Q3
$1.27M Sell
44,750
-59,750
-57% -$1.54M 0.96% 26
2024
Q2
$2M Buy
+104,500
New +$2.67M 1.65% 17

Other funds holding EVH

Forest Hill Capital's EVH Position: Q1 2026 in Review

Forest Hill Capital sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 150,250 shares — an estimated $601K sold.

Forest Hill Capital first reported a position in EVH in Q2 2024 and held it in 7 quarters. The position peaked at $2M in Q2 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Forest Hill Capital reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Forest Hill Capital sold 150,250 Evolent Health shares in Q1 2026, an estimated $601K.
  • Forest Hill Capital first reported a position in Evolent Health in Q2 2024 and held it in 7 quarters.
  • Forest Hill Capital's Evolent Health position peaked at $2M in Q2 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Forest Hill Capital's 13F filing for Q1 2026, filed 15 May 2026.